Cite
HARVARD Citation
Li, J. et al. (2017). Real-world cost–effectiveness of infliximab for moderate-to-severe rheumatoid arthritis in a medium-sized city of China. Journal of comparative effectiveness research. pp. 205-218. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, J. et al. (2017). Real-world cost–effectiveness of infliximab for moderate-to-severe rheumatoid arthritis in a medium-sized city of China. Journal of comparative effectiveness research. pp. 205-218. [Online].